Journal of Cardiac Failure
Volume 13, Issue 5 , Pages 360-364, June 2007

Prognostic Value of Blood Urea Nitrogen in Patients Hospitalized With Worsening Heart Failure: Insights From the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) Study

  • Gerasimos Filippatos, MD

      Affiliations

    • From the Department of Cardiology, Athens University, Athens, Greece
    • ,
  • Joseph Rossi, MD

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Donald M. Lloyd-Jones, MD, ScM

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Wendy Gattis Stough, PharmD

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, North Carolina
    • Campbell University School of Pharmacy Department of Clinical Research, Research Triangle Park, North Carolina
    • ,
  • John Ouyang, PhD

      Affiliations

    • Otsuka Maryland Research Institute, Rockville, Maryland
    • ,
  • David D. Shin

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Christopher O'Connor, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, North Carolina
    • ,
  • Kirkwood F. Adams, MD

      Affiliations

    • Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina
    • ,
  • Cesare Orlandi, MD

      Affiliations

    • Otsuka Maryland Research Institute, Rockville, Maryland
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • Corresponding Author InformationReprint requests: Mihai Gheorghiade, MD, Division of Cardiology, Northwestern University, Feinberg School of Medicine, Galter 10-240, 201 E Huron Street, Chicago, IL 60611.

Received 30 June 2006; received in revised form 12 January 2007; accepted 21 February 2007.

Athens, Greece; Chicago, Illinois; Durham, North Carolina; Research Triangle Park, North Carolina; Rockville, Maryland; Chapel Hill, North Carolina

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The ACTIV in CHF trial and this analysis were funded by Otsuka Maryland Research Institute, Rockville, Maryland.

PII: S1071-9164(07)00051-6

doi:10.1016/j.cardfail.2007.02.005

Journal of Cardiac Failure
Volume 13, Issue 5 , Pages 360-364, June 2007

Article Tools

* Image Usage & Resolution